WESTERN A-FIB SYMPOSIUM 2022

FRIDAY – FEBRUARY 25, 2022

07:00 – 07:30REGISTRATION, EXHIBITS & BREAKFAST SNACKS
07:30 – 07:45WELCOME & INTRODUCTIONS
Nassir F. Marrouche, MD

Session 1

CHAIRS: Hugh Calkins, MD; Melvin Scheinman, MD

07:45 – 07:55MY FIFTEEN YEARS AT WAF
Eric N. Prystowsky, MD 
07:55 – 08:05DIGITAL TREATMENT: IMPLEMENTING AI TO TREAT AF
Hamid Ghanbari, MD, MPH
08:05 – 08:15THE NEXT AF GUIDELINES WILL LOOK LIKE THIS
Gerhard Hindricks, MD, MBA, ProfDr.
08:15 – 08:25MY NEXT AF TREATMENT TRIAL
John Mandrola, MD
08:25 – 08:35THE IMPORTANCE OF ATRIAL MYOPATHY PROGRESSION: DECAAF II AND EDORA
Lilas Dagher, MD
08:35 – 08:55OPEN DISCUSSION
Session 1

CHAIRS: Hugh Calkins, MD; Melvin Scheinman, MD

07:45 – 07:55
MY FIFTEEN YEARS AT WAF
Eric N. Prystowsky, MD
07:55 – 08:05
DIGITAL TREATMENT: IMPLEMENTING AI TO TREAT AF
Hamid Ghanbari, MD, MPH
08:05 – 08:15
THE NEXT AF GUIDELINES WILL LOOK LIKE THIS
Gerhard Hindricks, MD, MBA, ProfDr.
08:15 – 08:25
MY NEXT AF TREATMENT TRIAL
John Mandrola, MD
08:25 – 08:35
THE IMPORTANCE OF ATRIAL MYOPATHY PROGRESSION: DECAAF II AND EDORA
Lilas Dagher, MD
08:35 – 08:55
OPEN DISCUSSION

Session 2

MODERATORS: Ahmad Abdul-Karim, MD; DJ Lakkireddy, MD, FACC, FHRS

08:55 – 09:55ROUNDTABLE: HOW OFTEN & HOW SHOULD I RE-ABLATE MY AF PATIENT: EXAMPLES FROM MY PRACTICE
Jason Andrade, MD; Walid Saliba, MD; Christian Sohns, MD; Alexis Ramirez, MD; Gaston R. Vargara, MD
09:55 – 10:10BREAK & EXHIBITS
Session 2

MODERATORS: Ahmad Abdul-Karim, MD; DJ Lakkireddy, MD, FACC, FHRS

08:55 – 09:55
ROUNDTABLE: HOW OFTEN & HOW SHOULD I RE-ABLATE MY AF PATIENT: EXAMPLES FROM MY PRACTICE
Jason Andrade, MD; Walid Saliba, MD; Christian Sohns, MD; Alexis Ramirez, MD; Gaston R. Vargara, MD
09:55 – 10:10
BREAK & EXHIBITS

Session 3

CHAIRS: Christian Mahnkopf, MD; Jeanne E. Poole, MD

10:10 – 10:20THE ‘CONVERGE’ TRIAL: THE FOLLOW-UP REDO PROCEDURES
David D. De Lurgio, MD, FACC, FHRS
10:20 – 10:30THE LATEST UPDATES ON OLD & NEW CRYOBALLOONS FOR A-FIB ABLATION
Suneet Mittal, MD
10:30 – 10:40ANALYSIS OF AF SOURCES WITH ELECTROGRAPHIC FLOW MAPPING
David E. Haines, MD
10:40 – 10:50OCCLUSION OF LEFT ATRIAL APPENDAGES: WHAT I LEARNED FROM LOOP
Walid Saliba, MD
10:50 – 11:15OPEN DISCUSSION
11:15 – 12:30LUNCH & EXHIBITS
Session 3

CHAIRS: Christian Mahnkopf, MD; Jeanne E. Poole, MD

10:10 – 10:20
THE ‘CONVERGE’ TRIAL: THE FOLLOW-UP REDO PROCEDURES
David D. De Lurgio, MD, FACC, FHRS
10:20 – 10:30
THE LATEST UPDATES ON OLD & NEW CRYOBALLOONS FOR A-FIB ABLATION
Suneet Mittal, MD
10:30 – 10:40
ANALYSIS OF AF SOURCES WITH ELECTROGRAPHIC FLOW MAPPING
David E. Haines, MD
10:40 – 10:50
OCCLUSION OF LEFT ATRIAL APPENDAGES: WHAT I LEARNED FROM LOOP
Walid Saliba, MD
10:50 – 11:15
OPEN DISCUSSION
11:15 – 12:30
11:30 – 12:15

Session 4

CHAIRS: Uzodinma C. Emerenini, MD; Christopher J. McGann, MD

12:30 – 12:40AF ABLATION: WHY IS EARLIER BETTER?
Jason Andrade, MD
12:40 – 12:50 FIBROSIS, STROKE & A-FIB: CLINICAL UPDATES & EMERGING MECHANISTIC MODELS
Nazem Akoum, MD
12:50 – 13:00STRATEGIES FOR PULMONARY VEIN ISOLATION: LESSONS FROM DECAAF II
Mihail G. Chelu, MD, PhD
13:00 – 13:10RISK FACTOR MODIFICATION AS AN INTEGRAL PART OF A-FIB MANAGEMENT
Eoin Donnellan, MD
13:10 – 13:30OPEN DISCUSSION
Session 4

CHAIRS: Uzodinma C. Emerenini, MD; Christopher J. McGann, MD

12:30 – 12:40
AF ABLATION: WHY IS EARLIER BETTER?
Jason Andrade, MD
12:40 – 12:50
AF ABLATION: WHY IS EARLIER BETTER?
Jason Andrade, MD
12:50 – 13:00
STRATEGIES FOR PULMONARY VEIN ISOLATION: LESSONS FROM DECAAF II
Mihail G. Chelu, MD, PhD
13:00 – 13:10
RISK FACTOR MODIFICATION AS AN INTEGRAL PART OF A-FIB MANAGEMENT
Eoin Donnellan, MD
13:10 – 13:30
OPEN DISCUSSION

Session 5

CHAIRS: Tina Baykaner, MD, MPH; Saman Nazarian, MD, PhD

13:30 – 13:40PERSONALIZATION OF PERSISTENT AF ABLATION AFTER DECAAF II: PROMISES & CHALLENGES
Nassir F. Marrouche, MD
13:40 – 13:50ADVANTAGES OF INTRACARDIAC 4D ECHO DURING AF ABLATION
Amin Al-Ahmad, MD
13:50 – 14:00MY TOP FIVE PRACTICE-CHANGING AF RELATED TWEETS OF 2021
Antonio Raviele, MD, FESC, FHRS
14:00 – 14:10THE ‘OPTION’ TRIAL: RATIONALE & UPDATE
Oussama M. Wazni, MD
14:10 – 14:20COMPREHENSIVE CARE DELIVERY FOR AF: NOVEL MODELS WE NEED TO STANDARDIZE
Prashanthan Sanders, MBBS, PhD
14:20 – 14:40OPEN DISCUSSION
14:40 – 14:55BREAK & EXHIBITS
Session 5

CHAIRS: Tina Baykaner, MD, MPH; Saman Nazarian, MD, PhD

13:30 – 13:40
PERSONALIZATION OF PERSISTENT AF ABLATION AFTER DECAAF II: PROMISES & CHALLENGES
Nassir F. Marrouche, MD
13:40 – 13:50
ADVANTAGES OF INTRACARDIAC 4D ECHO DURING AF ABLATION
Amin Al-Ahmad, MD
13:50 – 14:00
MY TOP FIVE PRACTICE-CHANGING AF RELATED TWEETS OF 2021
Antonio Raviele, MD, FESC, FHRS
14:00 – 14:10
THE ‘OPTION’ TRIAL: RATIONALE & UPDATE
Oussama M. Wazni, MD
14:10 – 14:20
COMPREHENSIVE CARE DELIVERY FOR AF: NOVEL MODELS WE NEED TO STANDARDIZE
Prashanthan Sanders, MBBS, PhD
14:20 – 14:40
OPEN DISCUSSION
14:40 – 14:55
BREAK & EXHIBITS

Session 6

CHAIRS: Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Christopher J. McGann, MD

14:55 – 15:05MY DIGITAL REMOTE INFRASTRUCTURE FOR ATRIAL FIBRILLATION MANAGEMENT
Dominik Linz
15:05 – 15:15SHORT & LONG -TERM ENDPOINTS OF MY AF ABLATION PROCEDURE IN 2022
Francis E. Marchlinski, MD
15:15 – 15:25ATRIAL IMAGING USING CARDIAC MRI: LESSONS FROM DECAAF II
Eugene Kholmovski, PhD
15:25 – 15:35TEMPORAL ASSOCIATION BETWEEN EPISODES OF AF & RISK OF ISCHEMIC STROKE
Rod S. Passman, MD, MSCE
15:35-15:55OPEN DISCUSSION
Session 6

CHAIRS: Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Christopher J. McGann, MD

14:55 – 15:05
MY DIGITAL REMOTE INFRASTRUCTURE FOR ATRIAL FIBRILLATION MANAGEMENT
Dominik Linz
15:05 – 15:15
SHORT & LONG -TERM ENDPOINTS OF MY AF ABLATION PROCEDURE IN 2022
Francis E. Marchlinski, MD
15:15 – 15:25
ATRIAL IMAGING USING CARDIAC MRI: LESSONS FROM DECAAF II
Eugene Kholmovski, PhD
15:25 – 15:35
TEMPORAL ASSOCIATION BETWEEN EPISODES OF AF & RISK OF ISCHEMIC STROKE
Rod S. Passman, MD, MSCE
15:35-15:55
OPEN DISCUSSION

Session 7

CHAIRS: Bradley P. Knight, MD; Elaine Y. Wan, MD

15:55 – 16:05

ELECTROPORATION OF AF: WILL IT BE STANDARD OF CARE IN TWO YEARS?
Pierre Jais, MD

16:05 – 16:15THE IMPACT OF DRONEDARONE ON ATRIAL FIBRILLATION BURDEN
Carina Blomstrom-Lundquist, MD, PhD
16:15 – 16:25THE DIGITAL MEDICINE CENTER AT TULANE: THE ENGINEERING PERSPECTIVE
Chan Ho Lim, MS
16:25 – 16:35THE HEARTLINE TRIAL: AN UPDATE
Mintu Turakhia, MD
16:35 – 16:45ATRIOVENTRICULAR JUNCTION ABLATION & CARDIAC RESYNCHRONIZATION THERAPY IN PERMANENT AF: APAF-CRT TRIAL
Michele Brignole, MD
16:45 – 17:05OPEN DISCUSSION
Session 7

CHAIRS: Bradley P. Knight, MD; Elaine Y. Wan, MD

15:55 – 16:05
ELECTROPORATION OF AF: WILL IT BE STANDARD OF CARE IN TWO YEARS?
Pierre Jais, MD
16:05 – 16:15
THE IMPACT OF DRONEDARONE ON ATRIAL FIBRILLATION BURDEN
Carina Blomstrom-Lundquist, MD, PhD
16:15 – 16:25
THE DIGITAL MEDICINE CENTER AT TULANE: THE ENGINEERING PERSPECTIVE
Chan Ho Lim, MS
16:25 – 16:35
THE HEARTLINE TRIAL: AN UPDATE
Mintu Turakhia, MD
16:35 – 16:45
ATRIOVENTRICULAR JUNCTION ABLATION & CARDIAC RESYNCHRONIZATION THERAPY IN PERMANENT AF: APAF-CRT TRIAL
Michele Brignole, MD
16:45 – 17:05
OPEN DISCUSSION

Session 8

MODERATORS: Saman Nazarian, MD, PhD; David J. Wilber, MD

17:05 – 17:45ROUNDTABLE: USING CARDIAC MRI IN A-FIB MANAGEMENT: WHO, WHEN & WHY?
Pierre Jais, MD; Christia Mahnkopf, MD; Luis Saenz, MD; Natalia Trayanova, MD, FHRS, FAIHA; Brent Wilson, MD, PhD
Session 8

MODERATORS: Saman Nazarian, MD, PhD; David J. Wilber, MD

17:05 – 17:45
ROUNDTABLE: USING CARDIAC MRI IN A-FIB MANAGEMENT: WHO, WHEN & WHY?
Pierre Jais, MD; Christia Mahnkopf, MD; Luis Saenz, MD; Natalia Trayanova, MD, FHRS, FAIHA; Brent Wilson, MD, PhD

Session 9

CHAIRS: Edward P. Gerstenfeld, MD; Edward J. Schloss, MD, FHRS

17:45 -17:55ABLATION & ANTI-ARRHYTHMICS FOR AF – TWO FACES OF THE SAME COIN? LESSONS FROM THE EAST-AF TRIAL
Paulus Kirchhof, MD
17:55 – 18:05

WHAT’S NEXT FOR ATRIAL FIBROSIS TARGETING IN A-FIB?
Felipe Bisbal, MD

18:05 – 18:15DEFINING ATRIAL STRUCTURAL REMODELING: MRI VS. VOLTAGE MAPPING
Antoine Chaanine, MD
18:15 – 18:25HIGH POWER SHORT DURATION FOR AF ABLATION: HOW HIGH & HOW SHORT?
Andrea Natale, MD, FHRS, FACC, FESC
18:25 – 18:45OPEN DISCUSSION
18:45ADJOURNMENT
Session 9

CHAIRS: Edward P. Gerstenfeld, MD; Edward J. Schloss, MD, FHRS

17:45 -17:55
ABLATION & ANTI-ARRHYTHMICS FOR AF – TWO FACES OF THE SAME COIN? LESSONS FROM THE EAST-AF TRIAL
Paulus Kirchhof, MD
17:55 – 18:05
WHAT’S NEXT FOR ATRIAL FIBROSIS TARGETING IN A-FIB?
Felipe Bisbal, MD
18:05 – 18:15
DEFINING ATRIAL STRUCTURAL REMODELING: MRI VS. VOLTAGE MAPPING
Antoine Chaanine, MD
18:15 – 18:25
HIGH POWER SHORT DURATION FOR AF ABLATION: HOW HIGH & HOW SHORT?
Andrea Natale, MD, FHRS, FACC, FESC
18:25 – 18:45
OPEN DISCUSSION
18:45
ADJOURNMENT

SATURDAY – FEBRUARY 26, 2022

06:30 – 07:30CHECK-IN, EXHIBITS & BREAKFAST SNACKS

Session 10

CHAIRS: Fred Kusumoto,MD; Luis Saenz, MD

07:30 – 07:40 ALCOHOL INTAKE & RISK OF STROKE IN A-FIB: THE LESSER THE BETTER, BUT BETTER IS NOT ENOUGH
Andrea M. Russo, MD
07:40 – 07:50THE AF-FICIENT TRIAL: ONE YEAR OUTCOMES
Vivek Reddy, MD
07:50 – 08:00HOW DOES WEIGHT LOSS AFFECT AF? FROM PATHOLOGY TO CLINICAL OUTCOMES
TBA
08:00- 08:10HOW DIGITAL HEALTH CHANGED ADOPTION OF CHADVASC IN MY AF PRACTICE
Christine Albert, MD, MPH
08:10 – 08:20ATRIAL FIBRILLATION AT HRS: THE CEO PROSPECTIVE
Patricia Blake
08:20 – 08:40OPEN DISCUSSION
Session 10

CHAIRS: Fred Kusumoto,MD; Luis Saenz, MD

07:30 – 07:40
ALCOHOL INTAKE & RISK OF STROKE IN A-FIB: THE LESSER THE BETTER, BUT BETTER IS NOT ENOUGH
Andrea M. Russo, MD
07:40 – 07:50
THE AF-FICIENT TRIAL: ONE YEAR OUTCOMES
Vivek Reddy, MD
07:50 – 08:00
HOW DOES WEIGHT LOSS AFFECT AF? FROM PATHOLOGY TO CLINICAL OUTCOMES
TBA
08:00- 08:10
HOW DIGITAL HEALTH CHANGED ADOPTION OF CHADVASC IN MY AF PRACTICE
Christine Albert, MD, MPH
08:10 – 08:20
ATRIAL FIBRILLATION AT HRS: THE CEO PROSPECTIVE
Patricia Blake
08:20 – 08:40
OPEN DISCUSSION

Session 11

MODERATORS: Andrea Natale, MD, FHRS, FACC, FESC; Philipp Sommer, MD

08:40 – 09:05ROUNDTABLE: THE ABLATION LESION FORMATION DILEMMA: HOW WE STANDARDIZE TREATMENT DELIVERY IN ABLATION TRIALSDavid J. Callans MD; Thomas Deneke, MD, PhD; Gregory F. Michaud, MD; Luis Mont, MD; Darryl S. Wells, MD
Session 11

MODERATORS: Andrea Natale, MD, FHRS, FACC, FESC; Philipp Sommer, MD

08:40 – 09:05
ROUNDTABLE: THE ABLATION LESION FORMATION DILEMMA: HOW WE STANDARDIZE TREATMENT DELIVERY IN ABLATION TRIALSDavid J. Callans MD; Thomas Deneke, MD, PhD; Gregory F. Michaud, MD; Luis Mont, MD; Darryl S. Wells, MD

Session 12

CHAIRS: Christine Albert, MD, MPH; Johannes Brachmann, Prof, Dr.

09:05 – 09:15ISCHEMIC STROKE IN ANTICOAGULATED PATIENTS WITH A-FIB
M. Edip Gurol, MD
09:15 – 09:25DECAAF RE-DO
Christian Sohns, MD
09:25 – 09:35EXTENSIVE ABLATION OF LEFT ATRIAL TISSUE: WEIGHING ON ATRIAL FUNCTION?
Philipp Sommer, MD
09:35 – 09:45THE NEWEST INNOVATIONS FOR ESOPHAGEAL PROTECTION DURING AF ABLATION
Emile Daoud, MD
09:45 – 09:55ELECTRICAL MASS & ATRIAL FIBRILLATION: IMPLICATIONS FOR THERAPY
Andrew Krahn, MD
09:55 – 10:10OPEN DISCUSSION
10:10 – 10:25BREAK & EXHIBITS
Session 12

CHAIRS: Christine Albert, MD, MPH; Johannes Brachmann, Prof, Dr.

09:05 – 09:15
ISCHEMIC STROKE IN ANTICOAGULATED PATIENTS WITH A-FIB
M. Edip Gurol, MD
09:15 – 09:25
DECAAF RE-DO
Christian Sohns, MD
09:25 – 09:35
EXTENSIVE ABLATION OF LEFT ATRIAL TISSUE: WEIGHING ON ATRIAL FUNCTION?
Philipp Sommer, MD
09:35 – 09:45
THE NEWEST INNOVATIONS FOR ESOPHAGEAL PROTECTION DURING AF ABLATION
Emile Daoud, MD
09:45 – 09:55
ELECTRICAL MASS & ATRIAL FIBRILLATION: IMPLICATIONS FOR THERAPY
Andrew Krahn, MD
09:55 – 10:10
OPEN DISCUSSION
10:10 – 10:25
BREAK & EXHIBITS

Session 13

MODERATORS: Jason Andrade, MD; Nassir Marrouche, MD

10:25 – 11:05ROUNDTABLE: IF I WERE TO DESIGN THE NEXT AF IN HF TRIAL
Sana M. Al Khatib, MD; John D. Day, MD; Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Gerhard Hindricks, MD; Douglas L. Packer, MD
Session 13

MODERATORS: Jason Andrade, MD; Nassir Marrouche, MD

10:25 – 11:05
ROUNDTABLE: IF I WERE TO DESIGN THE NEXT AF IN HF TRIAL
Sana M. Al Khatib, MD; John D. Day, MD; Thomas F. Deering, MD, MBA, FHRS, FACC, FACP; Gerhard Hindricks, MD; Douglas L. Packer, MD

Session 14

CHAIR: Antonio Raviele, MD, FESC, FHRS

11:05 – 11:15SEX DIFFERENCES IN PROCEDURAL OUTCOMES AMONG PATIENTS UNDERGOING LEFT ATRIAL APPENDAGE OCCLUSION
Sana M. Al-Khatib, MD, MHS
11:15 – 11:25HOW PFA CAN IMPACT SHORT & LONG -TERM OUTCOMES OF AF
Moussa C. Mansour, MD
11:25 – 11:35FIBROSIS & ROTORS: PUTTING IT TOGETHER
Tina Baykaner, MD, MPH
11:35 – 11:45WHICH OUTCOMES SHOULD REALLY MATTER AFTER ABLATION OF ATRIAL FIBRILLATION?
David J. Wilber, MD
11:45 – 11:55MY TAILORED PERSISTENT AF ABLATION PROCEDURE IN 2022
Gregory F. Michaud, MD
11:55 – 12:10OPEN DISCUSSION
12:10 – 13:10LUNCH & EXHIBITS
Session 14

CHAIR: Antonio Raviele, MD, FESC, FHRS

11:05 – 11:15
SEX DIFFERENCES IN PROCEDURAL OUTCOMES AMONG PATIENTS UNDERGOING LEFT ATRIAL APPENDAGE OCCLUSION
Sana M. Al-Khatib, MD, MHS
11:15 – 11:25
HOW PFA CAN IMPACT SHORT & LONG -TERM OUTCOMES OF AF
Moussa C. Mansour, MD
11:25 – 11:35
FIBROSIS & ROTORS: PUTTING IT TOGETHER
Tina Baykaner, MD, MPH
11:35 – 11:45
TARGETING FIBROSIS IN AF ABLATION: THE DECAAF TRIALS
David J. Wilber, MD
11:45 – 11:55
MY TAILORED PERSISTENT AF ABLATION PROCEDURE IN 2022
Gregory F. Michaud, MD
11:55 – 12:10
OPEN DISCUSSION
12:10 – 13:10
LUNCH & EXHIBITS

Session 15

CHAIRS: Dhiraj Gupta, FRCP; Roderick Tung, MD

13:10 – 13:20RE-EXAMINING THE EMBOLIC STROKE OF UNDETERMINED SOURCE CONCEPT
Elaine M. Hylek, MD, MPH
13:20 – 13:30THE AF BURDEN LESSON FROM MULTI-CENTER TRIALS
Jeanne E. Poole, MD FHRS, FACC
13:30 – 13:40LEADING THE WAY FOR COMPREHENSIVE AF CARE: THE HORIZON 2020 EHRA-PATHS PROJECT
Isabelle Van Gelder, MD
13:40 – 13:50CAN MY ML ALGORITHM HELP ME MANAGE MY AF PATIENT?
Sanjiv M. Narayan, MD, PhD
13:50 – 14:00CVDHJ: TOP FIVE ARTICLES IN 2021
David McManus, MD
14:00 – 14:20OPEN DISCUSSION
Session 15

CHAIRS: Dhiraj Gupta, FRCP; Roderick Tung, MD

13:10 – 13:20
RE-EXAMINING THE EMBOLIC STROKE OF UNDETERMINED SOURCE CONCEPT
Elaine M. Hylek, MD, MPH
13:20 – 13:30
THE AF BURDEN LESSON FROM MULTI-CENTER TRIALS
Jeanne E. Poole, MD FHRS, FACC
13:30 – 13:40
LEADING THE WAY FOR COMPREHENSIVE AF CARE: THE HORIZON 2020 EHRA-PATHS PROJECT
Isabelle Van Gelder, MD
13:40 – 13:50
CAN MY ML ALGORITHM HELP ME MANAGE MY AF PATIENT?
Sanjiv M. Narayan, MD, PhD
13:50 – 14:00
CVDHJ: TOP FIVE ARTICLES IN 2021
David McManus, MD
14:00 – 14:20
OPEN DISCUSSION

Session 16

CHAIRS: Mikhael El Chami, MD; Natalia Trayanova, MD, PhD, FHRS, FAHA

14:20 – 14:30THE IMPORTANCE OF ATRIAL REMODELING DURING CARDIAC SURGERY PROCEDURES: THE SAPPORO TRIAL
Ralph J. Damiano, Jr., MD
14:30 – 14:40CARDIAC IMAGING GUIDANCE AS AN ADJUNCT TO THE ELECTROPHYSIOLOGICAL GUIDED APPROACH FOR ABLATION AF
Saman Nazarian, MD, PhD
14:40 – 14:50WEARABLES IN EP: HRS GUIDANCE FOR CONSUMERS & PROVIDERS
Elaine Y Wan, MD
14:50 – 15:00THE INS & OUTS OF ATRIAL FIBRILATION IN MITRAL REGURGITATION
James D. Thomas, MD
15:00 – 15:10SAME DAY DISCHARGE AFTER AF ABLATION
Thomas Deneke, MD, PhD
15:10 – 15:30OPEN DISCUSSION
15:30 – 15:50BREAK & EXHIBITS
Session 16

CHAIRS: Jason Andrade, MD; Mikhael El Chami, MD

14:20 – 14:30
THE IMPORTANCE OF ATRIAL REMODELING DURING CARDIAC SURGERY PROCEDURES: THE SAPPORO TRIAL
Ralph J. Damiano, Jr., MD
14:30 – 14:40
CARDIAC IMAGING GUIDANCE AS AN ADJUNCT TO THE ELECTROPHYSIOLOGICAL GUIDED APPROACH FOR ABLATION AF
Saman Nazarian, MD, PhD
14:40 – 14:50
WEARABLES IN EP: HRS GUIDANCE FOR CONSUMERS & PROVIDERS
Elaine Y Wan, MD
14:50 – 15:00
COMBINING CARDIAC MRI & ARTIFICIAL INTELLIGENCE FOR PREDICTION OF ABLATION OUTCOMES
Natalia Trayanova, PhD, FHRS, FAHA
15:00 – 15:10
SAME DAY DISCHARGE AFTER AF ABLATION
Thomas Deneke, MD, PhD
15:10 – 15:30
OPEN DISCUSSION
15:30 – 15:50
BREAK & EXHIBITS

Session 17

CHAIRS: Edward P. Gerstenfeld, MD; Janet K. Han, MD, FACC, FHRS

15:50 – 16:00IMPROVEMENT IN HARD OUTCOMES FOLLOWING CATHETER ABLATION FOR A-FIB: THE DEBATE IS FAR FROM OVER
Dhiraj Gupta, FRCP
16:00 – 16:10IMAGING ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS & MANAGEMENT OF ARRHYTHMIAS
Natalia Trayanova, PhD, FHRS, FAHA
16:10 – 16:20PREVENTING COGNITIVE IMPAIRMENT IN AF
T. Jared Bunch, MD
16:20 – 16:30PREDICTORS OF PROCEDURAL OUTCOMES AFTER LAA OCCLUSION
Boris Schmidt, Dr.
16:30 – 16:40PACS AND AF: CAUSE OR CONSEQUENCE?
Jonathan Hsu, MD
16:40 – 17:00OPEN DISCUSSION
Session 17

CHAIRS: Janet K. Han, MD, FACC, FHRS

15:50 – 16:00
IMPROVEMENT IN HARD OUTCOMES FOLLOWING CATHETER ABLATION FOR A-FIB: THE DEBATE IS FAR FROM OVER
Dhiraj Gupta, FRCP
16:00 – 16:10
IMAGING ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS & MANAGEMENT OF ARRHYTHMIAS
Natalia Trayanova, PhD, FHRS, FAHA
16:10 – 16:20
PREVENTING COGNITIVE IMPAIRMENT IN AF
T. Jared Bunch, MD
16:20 – 16:30
PREDICTORS OF PROCEDURAL OUTCOMES AFTER LAA OCCLUSION
Boris Schmidt, Dr.
16:30 – 16:40
PACS AND AF: CAUSE OR CONSEQUENCE?
Jonathan Hsu, MD
16:40 – 17:00
OPEN DISCUSSION

Session 18

MODERATORS: Janet K. Han, MD, FACC, FHRS; Edward J. Schloss, MD, FHRS

17:00 – 18:00ROUNDTABLE: #ASKWAF
John D. Day, MD; Edward P. Gerstenfeld, MD; Melanie True Hills, CSP; Jodie L. Hurwitz, MD; Leenhapong Navaravong, MD, FACC, FHRS
18:00ADJOURNMENT
Session 18

MODERATORS: Janet K. Han, MD, FACC, FHRS; Edward J. Schloss, MD, FHRS

17:00 – 18:00
ROUNDTABLE: #ASKWAF
John D. Day, MD; Edward P. Gerstenfeld, MD; Melanie True Hills, CSP; Jodie L. Hurwitz, MD; Leenhapong Navaravong, MD, FACC, FHRS
18:00
ADJOURNMENT